Ischemic cardiomyopathy
Mehdi Mehrania; Seyed Hesameddin Abbasia; Ahmad Aminb; Seyed Ebrahim Kassaiana; Morteza Mahmoudic a Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
b Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Science, Tehran, Iran
c Precision Health Program, Michigan State University, East Lansing, MI, United States
Abstract
In this section, we will overview a summary of the mechanisms involved in the occurrence and progress of ischemic cardiomyopathy including pathophysiology of the heart failure and the associated roles of stunned and hibernating myocardium. We also briefly discuss how reperfusion process can cause injuries to the myocardium. Ultimately, we will summarize the stages in the development of heart failure and the conventional diagnostic approaches to identify each stage.
Keywords
Stunned myocardium; Hibernating myocardium; Reperfusion injury; Clinical implications of heart failure
Pathophysiology of heart failure
Ischemic cardiomyopathy is the result of pathophysiological conditions disturbing the balance between perfusion and contraction [1]. The main reason for this mismatch between perfusion and contraction is the irreversible loss of the myocardium after myocardial infarction, which leads to myocardial fibrosis and eventually a āremodelingā process [2]. As the initial phase after MI, remodeling results from fibrotic repair of the necrotic area with scar formation, and consequences include thinning and myocyte elongation of the infarcted area. At first, these changes are beneficial and associated with maintaining or even improving cardiac output. However, the remodeling process is driven predominantly by hypertrophic myocyte elongation in the noninfarcted zone.
This cellular rearrangement of the ventricular wall is associated with a significant rise in the LV volume, rendering it less elliptical and more spherical [3], with the magnitude of the remodeling being roughly related to the infarct size [4].
The myocardium consists of myocytes tethered together and supported by a connective tissue network composed largely of fibrillar collagen. The interstitium contains mainly of type I and type III collagen fibers, which are resistant to degradation by most proteases. Some enzymes, including metalloproteinases, have collagenolytic activity. In the wake of myocardial infarction, fibroblast stimulation augments collagen synthesis and begets fibrosis of both the infarcted and noninfarcted regions of the myocardium. In the healthy heart, metalloproteinases are present in their inactive form in the ventricle; however, myocardial injury triggers the activation of these proteases [5] and thus contributes to an increase in the chamber dimension and subsequent processes including myocyte slippage, which is thought to contribute to chamber remodeling [6]. For example, the marked overexpression of MMP-9 after myocardial infarction may be a mediator of collagen accumulation and remodeling [7, 8].
There is an association between progressive heart failure and neurohumoral activation, which may initially be regarded as compensatory but may further the progression of structural abnormalities. For example, the concentration of plasma brain natriuretic peptide (BNP), which has some capacity to protect the failing heart against pathologic remodeling [9], is increased in progressive HF and is positively correlated with prognosis [10]. Another example is angiotensin-converting enzyme (ACE). In several clinical trials, its elevated inhibitors demonstrated improved survival after HF and can slow, and in some cases, even reverse certain parameters of cardiac remodeling [10, 11]. Research has shown that impaired LV function in patients with coronary heart disease is not always irreversible. It is noteworthy that transient postischemic dysfunction is termed āstunnedā myocardium, while chronic but potentially reversible ischemic dysfunction due to a stenosed coronary artery is called āhibernatingā myocardium.
Pathophysiology of stunned or hibernating myocardium
LV dysfunction is a significant consequence of CAD and can arise from either myocardial ischemia or myocardial infarction [12]. The term āstunned myocardiumā was initially used to describe a condition demonstrated in the laboratory in which a total coronary artery occlusion lasting only between 5 and 15 min (a period not associated to cell death) created an abnormality in the regional LV wall motion that lingered for hours or days after reperfusion [13ā15]. Consequently, the chief characteristics of the stunned myocardium scenario are short-term, total, or near-total decrease in coronary blood flow; reestablishment of the coronary blood flow; and resultant LV dysfunction of limited duration. In the clinical setting, there is a likelihood of the superimposition of stunned myocardium on ischemia or infarction following the reestablishment of blood flow [16].
The term āhibernating myocardiumā denotes a condition in which myocardial and LV functions are persistently impaired at rest, secondary to a chronically diminished coronary blood flow that can be partially or fully restored to the normal state either through augmenting blood flow or by decreasing oxygen demand [17, 18].
Failure to provide timely treatment for hibernating myocardium may lead to progressive cellular damage, recurrent myocardial ischemia, myocardial infarction, heart failure, and ultimately death [19]. In patients undergoing revascularization, the presence of hibernating myocardium foretells an improvement in the chances of survival [20].
A meta-analysis of 24 viability studies on 3088 patients suffering from CAD and LV dysfunction with a mean left ventricular ejection fraction (LVEF) of 32% reported a rate of 42% for the prevalence of hibernating myocardium viability [21].
Reperfusion injury
Myocardial injury in the context of acute myocardial infarction is a consequence of ischemic and reperfusion injury. Reperfusion therapies such as fibrinolysis therapy and primary percutaneous coronary intervention swiftly restore blood flow to the ischemic myocardium and curb infarct size. Unexpectedly, nonetheless, the reestablishment of blood flow can beget additional cardiac damage and complications, referred to as reperfusion injury [22ā24].
Reperfusion injury is typified by vascular, myocardial, or electrophysiological dysfunction brought about by the return of blood flow to ischemic tissue. When the blood flow to cardiac myocytes is disrupted by the occlusion of a coronary artery, a series of events results in cellular injury and death.
In the context of acute myocardial infarction, it has been posited that reperfusion injury is responsible for up to 50% of the final myocardial damage [25]. One of the main side effects of reperfusion injury is generation of reactive oxygen species (ROS), which are produced by several processes/pathways involving the myocardium and/or infiltrating inflammatory cells [26ā28]. ROS deteriorate vital functions of ...